GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Assertio Holdings Inc (FRA:DPOA) » Definitions » Cyclically Adjusted PS Ratio

Assertio Holdings (FRA:DPOA) Cyclically Adjusted PS Ratio : (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Assertio Holdings Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Assertio Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Assertio Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assertio Holdings Cyclically Adjusted PS Ratio Chart

Assertio Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.08 0.13 0.24 0.06

Assertio Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.30 0.14 0.06 0.06

Competitive Comparison of Assertio Holdings's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Assertio Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assertio Holdings's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Assertio Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Assertio Holdings's Cyclically Adjusted PS Ratio falls into.



Assertio Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Assertio Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Assertio Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.367/131.7762*131.7762
=0.367

Current CPI (Mar. 2024) = 131.7762.

Assertio Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.825 100.560 1.081
201409 0.656 100.428 0.861
201412 1.980 99.070 2.634
201503 0.500 99.621 0.661
201506 1.404 100.684 1.838
201509 1.549 100.392 2.033
201512 1.684 99.792 2.224
201603 1.545 100.470 2.026
201606 1.698 101.688 2.200
201609 1.603 101.861 2.074
201612 1.904 101.863 2.463
201703 1.361 102.862 1.744
201706 1.430 103.349 1.823
201709 1.271 104.136 1.608
201712 1.263 104.011 1.600
201803 1.272 105.290 1.592
201806 0.850 106.317 1.054
201809 0.803 106.507 0.994
201812 0.583 105.998 0.725
201903 0.798 107.251 0.980
201906 0.785 108.070 0.957
201909 0.688 108.329 0.837
201912 0.659 108.420 0.801
202003 0.266 108.902 0.322
202006 0.225 108.767 0.273
202009 0.361 109.815 0.433
202012 0.305 109.897 0.366
202103 0.277 111.754 0.327
202106 0.259 114.631 0.298
202109 0.266 115.734 0.303
202112 0.363 117.630 0.407
202203 0.408 121.301 0.443
202206 0.409 125.017 0.431
202209 0.425 125.227 0.447
202212 0.584 125.222 0.615
202303 0.488 127.348 0.505
202306 0.465 128.729 0.476
202309 0.410 129.860 0.416
202312 0.372 129.419 0.379
202403 0.367 131.776 0.367

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Assertio Holdings  (FRA:DPOA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Assertio Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Assertio Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Assertio Holdings (FRA:DPOA) Business Description

Traded in Other Exchanges
Address
100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Assertio Holdings (FRA:DPOA) Headlines

No Headlines